Delivery Order SPE2DB20D1004-SPE2DB25FNDWP

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $6.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB20D2002|SPE2DB25FL10P, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $5,113.64, is for the delivery of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 27, 2024. The contract was...
This federal contract award SPE2DB20D2002|SPE2DB25FL11H, with a ceiling value of $6,151.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 31, 2024. This contract is not designated as a set-aside award....
This federal contract award, identified as SPE2DB20D3505 and SPE2DB24FT6K5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,673.14, is for the delivery of Jardiance 25 mg tablets. This is a Firm Fixed Price Delivery Order contract with a completion date of January 23, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL7AX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $55,114.13 firm-fixed-price delivery order is for the provision of 4566796587 JARDIANCE 10 MG TABLET 90S, a pharmaceutical product, with a completion date of December 27, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with ID SPE2DB24D1034|SPE2DB25FVZB1, is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,921.12 contract is for the delivery of JARDIANCE 25 MG TABLET 90S medication. The award has a firm fixed price pricing type and an ultimate completion date of December 11, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of pharmaceutical products, specifically JARDIANCE 10 MG TABLET 90S. The contract has a firm fixed price pricing type and a ceiling value of $1,232.94. The award was made on August 13, 2024, with an ultimate completion date of August 14, 2024. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award SPE2DB22D1017|SPE2DB25FF2FX was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, is for the delivery of Jardiance 10 mg tablets in 90-count packages, with a ceiling value of $2,373.68 and a performance period ending on December 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB24D2010|SPE2DB25FZUA6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $22,116.58, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for...
This federal contract award, with an ID of SPE2DB24D1006|SPE2DB25FCEAL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price, has a ceiling value of $2,491.79 and an ultimate completion date of December 27, 2024. The contract is for the provision of 90-count tablets of the medication Jardiance 10 mg. This award is part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $2,222.82, is for the delivery of JARDIANCE 10 MG TABLET 30S, a prescription medication. This is a firm fixed-price delivery order contract, with a period of performance through May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNDWP
    Delivery Order

This contract award, SPE2DB20D1004|SPE2DB25FNDWP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4566824592 JARDIANCE 10 MG TABLET 90S. The fixed-price contract has a ceiling value of $6,662.62 and a period of performance through January 3, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov) since 2002. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside.

Generated 4/6/25, 12:50 AM